Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals

被引:0
作者
Andrew A. Crawford
Sarah Lewis
David Nutt
Tim J. Peters
Philip Cowen
Michael C. O’Donovan
Nicola Wiles
Glyn Lewis
机构
[1] University of Bristol,School of Social and Community Medicine
[2] Imperial College,Department of Neuropsychopharmacology
[3] University of Bristol,School of Clinical Sciences
[4] University of Oxford,Department of Psychiatry, Warneford Hospital
[5] Cardiff University,MRC Centre for Neuropsychiatric Genetics and Genomics, School of Medicine
[6] University College London,Mental Health Sciences Unit
来源
Psychopharmacology | 2014年 / 231卷
关键词
Adverse effects; Antidepressants; Citalopram; Depression; Noradrenaline reuptake inhibitor; NARI; Selective serotonin reuptake inhibitor; SSRI; Reboxetine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2921 / 2931
页数:10
相关论文
共 276 条
[1]  
Anderson IM(2000)Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability J Affect Disord 58 19-36
[2]  
Anderson IM(2008)Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines J Psychopharmacol 22 343-396
[3]  
Ferrier IN(2011)Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction Pharmacol Rev 63 811-859
[4]  
Baldwin RC(1995)The 5-HT3 antagonist ondansetron reduces gastrointestinal side-effects induced by a specific serotonin reuptake inhibitor in man J Psychopharmacol 9 137-141
[5]  
Cowen PJ(1961)An inventory for measuring depression Arch Gen Psychiatry 4 561-571
[6]  
Howard L(2002)Discontinuing or switching selective serotonin-reuptake inhibitors Ann Pharmacother 36 578-584
[7]  
Lewis G(2009)Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis Lancet 373 746-758
[8]  
Matthews K(2003)Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder Int Clin Psychopharmacol 18 151-156
[9]  
McAllister-Williams RH(1998)Compliance with medication regimens for mental and physical disorders Psychiatr Serv 49 196-201
[10]  
Peveler RC(2001)Compliance with antidepressants in a primary care setting, 1: beyond lack of efficacy and adverse events J Clin Psychiatry 62 30-33